Skip Nav Destination
Close Modal
Update search
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-2 of 2
Keywords: Phosphodiesterase 5 inhibitor
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Tadalafil 5 mg Once Daily Improved Each IPSS Subscore, QOL, and Nocturia in Elderly BPH Patients over 70 Years Old in a Real-World Clinical Setting
Available to PurchaseSubject Area:
Further Areas
Takahira Kuno, Kenji Tamura, Hideo Fukuhara, Satoshi Fukata, Shingo Ashida, Takashi Karashima, Kohji Sawada, Masaharu Yasuda, Hironobu Watanabe, Fumito Komatsu, Hajime Kuroiwa, Motoaki Saito, Keiji Inoue
Journal:
Urologia Internationalis
Urol Int (2022) 106 (10): 1005–1011.
Published Online: 21 October 2021
.... Evaluation by age group Lower urinary tract symptoms Phosphodiesterase 5 inhibitor Prostatic hyperplasia Tadalafil Benign prostatic hypertrophy (BPH) is a disease that causes dysuria by increasing urethral resistance due to an enlarged prostate gland. While the cause is unknown, BPH is thought...
Journal Articles
Tadalafil Improves Nocturia and Nocturia-Related Quality of Life in Patients with Benign Prostatic Hyperplasia (KYU-PRO Study)
Available to PurchaseSubject Area:
Further Areas
Ryosuke Takahashi, Yasuhiro Sumino, Minoru Miyazato, Hisae Nishii, Takuma Oshiro, Hiromitsu Mimata, Seiichi Saito, Masaki Yoshida, Masatoshi Eto
Journal:
Urologia Internationalis
Urol Int (2020) 104 (7-8): 587–593.
Published Online: 07 August 2020
... hyperplasia Phosphodiesterase 5 inhibitor Night-time voiding (nocturia) is one of the most bothersome symptoms in men with lower urinary tract symptoms (LUTS)/benign prostatic hyperplasia (BPH), and it is highly prevalent in community-dwelling men [ 1 ]. Pharmacological therapies with α1-blockers...
